Dose- and time-dependent changes in tissue levels of tetrabromobisphenol A (TBBPA) and its sulfate and glucuronide conjugates following repeated administration to female Wistar Han Rats

Toxicology Reports

Volumn 3, Issue , 2016, Pages 190-201

  Borghoff, S J ^a   Wikoff, D ^b   Harvey, S ^c   Haws, L ^b  

^a ToxStrategies Inc   (United States)

^b ToxStrategies Inc   (United States)

^c ToxStrategies Inc   (United States)

Author keywords

Estrogen sulfotransferases; Glucuronidation; Liver; TBBPA; Uterus

Indexed keywords

ESTRADIOL; GLUCURONOSYLTRANSFERASE 1A7; TETRABROMOBISPHENOL A; TETRABROMOBISPHENOL A GLUCURONIDE; TETRABROMOBISPHENOL A SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; IC50; LIQUID CHROMATOGRAPHY; LIVER WEIGHT; MASS SPECTROMETRY; NONHUMAN; RAT; UTERUS TUMOR; UTERUS WEIGHT;

EID: 84955611397     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2016.01.007     Document Type: Article

References (43)

1. Blom M.J., Wassink M.G., Kloosterboer H.J., Ederveen A.G., Lambert J.G., Goos H.J. Metabolism of estradiol, ethynylestradiol, and moxestrol in rat uterus, vagina, and aorta: influence of sex steroid treatment. Drug Metab. Dispos. 2001, 29:76-81.
2. Bromine Science and Environmental forum (BSEF) TBBPA Factsheet Brominated Flame Retardant In Tetrabromobisphenol A for Printed Circuit Boards and ABS Plastics 2012, Bromine Science and Environmental forum. http://www.bsef.com.
3. Colnot T., Kacew S., Dekant W. Mammalian toxicology and human exposures to the flame retardant 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol (TBBPA): implications for risk assessment. Arch. Toxicol. 2014, 88(3):553-573.
4. Coughtrie M.W.H. Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J. 2002, 2:297-308.
5. Dunn R.T., Klaassen C.D. Tissue-specific expression of rat sulfotransferase messenger RNAs. Drug Metab. Dispos. 1998, 26:598-604.
6. Dunnick J.K., Sanders J.M., Kissling G.E., Johnson C.L., Boyle M.H., Elmore S.A. Environmental chemical exposure may contribute to uterine cancer development: studies with tetrabromobisphenol A. Toxicol. Pathol. 2015, 43:464-473.
7. European Food Safety Administration (EFSA) Scientific opinion on tetrabromobisphenol A (TBBPA) and its derivatives in food. EFSA J. 2011, 9(12):2477. 10.2903/j.efsa.2011.2477.
8. European Union (EU) Risk Assessment Report: 2,2',6,6'-Tetrabromo-4,4'-Isopropylidenediphenol (Tetrabromobisphenol-a or TBBP-A), Part II-Human Health 2006, 63. European Union.
9. Falany J.L., Azziz R., Falany C.N. Identification and characterization of cytosolic sulfotransferases in normal human endometrium. Chem. Biol. Interact. 1998, 109:329-339.
10. Gosavi R.A., Knudsen G.A., Birnbaum L.S., Pedersen L.C. Mimicking of estradiol binding by flame retardants and their metabolites: a crystallographic analysis. Environ. Health Perspect. 2013, 121(10):1194-1199.
11. Guillemette C., Belanger A., Lepine J. Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res. 2004, 6(6):246-254.
12. Hakk H., Larsen G., Bergman A., Orn U. Metabolism, excretion and distribution of the flame retardant tetrabromoobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 2000, 30(9):881-890.
13. Hamers T., Kamstra J.H., Sonneveld E., Murk A.J., Kester M.H., Andersson P.L., Legler J., Brouwer A.J. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol. Sci. 2006, 92:157-173.
14. Harju M., Hamers T., Kamstra J.H., Sonneveld E., Boon J.P., Tysklind M., Andersson P.L. Quantitative structure-activity relationship modeling on in vitro endocrine effects and metabolic stability involving 26 selected brominated flame retardants. Environ. Toxicol. Chem. 2007, 26:816-826.
15. Health Canada/Environment Canada Screening Assessment Report: Phenol, 4,4'-(1-methylethylidene) bis[2,6-dibromo- (Chemical Abstracts Service Registry Number 79-94-7), Ethanol, 2,2'-[(1-methylethylidene) bis[(2,6-dibromo-4,1-phenylene) oxy]]bis (Chemical Abstracts Service Registry Number 4162-45-2), Benzene, 1,1'-(1methylethylidene) bis[3,5-dibromo-4-(2-propenyloxy)-(Chemical Abstracts Service Registry Number 25327-89-3) Health Canada/Environment Canada, 2013; ISBN: 978-1-100-22898-3.
16. International Agency for Research on Cancer (IARC) Pharmaceuticals: A Review of Human Carcinogens IARC Monographs 2012, vol. 100 A. International Agency for Research on Cancer, Available at: http://monographs.iarc.fr/ENG/Monographs/vol100A/mono100A.pdf.
17. Institute for Laboratory Animal Research (IIAR) Guide for the Care and Use of Laboratory Animals 2011, The National Academies Press, Washington, DC 20001, ISBN: 978-0-309-15401-7.
18. IPCS/WHO Tetrabromobisphenol A and Derivatives 1995, World Health Organization, Geneva, Available at: http://www.inchem.org/documents/ehc/ehc/ehc172.htm.
19. Jakobsson K., Thuresson K., Rylander L., Sjodin A., Hagmar L., Bergman A. Exposure to polybrominated diphenyl ethers and tetrabromobisphenol A among computer technicians. Chemosphere 2002, 46(5):709-716.
20. Kang M.J., Kim J.H., Shin S., Choi J.H., Lee S.K., Kim H.S., Kim N.D., Kang G.W., Jeong H.G., Kang W., Chun Y.J., Jeong T.C. Nephrotoxic potential and toxicokinetics of tetrabromobisphenol A in rat for risk assessment. J. Toxicol. Environ. Health A 2009, 72:1439-1445.
21. Kester M.H.A., Bulduck S., van Toor H., Tibboel D., Meinl W., Glatt H., Falany C.N., Coughtrie M.W.H., Schuur A.G., Brouwer A., Visser T.J. Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J. Clin. Endocrinol. Metab. 2002, 87:1142-1150.
22. Klaassen C.D., Boles J.W. The importance of 3'-phosphoadenosine 5'-phophosulfate (PAPS) in the regulation of sulfation. FASEB J. 1997, 11(6):404-418.
23. Klaunig J.E., Dekant W., Plotzke K., Scialli A.R. Biological relevance of decamethylcyclopentasiloxane (D5) induced rat uterine endometrial adenocarcinoma tumorigenesis: mode of action and relevance to humans. Regul. Toxicol. Pharmacol. 2015, 10.1016/j.yrtph.2015.06.021.
24. Knudsen G.A., Sanders J.M., Sadik A.M., Birnbaum L.S. Disposition and kinetics of tetrabromobisphenol A in female Wistar Han rats. Toxicol. Rep. 2014, 1:214-223.
25. Kuester R., Solyom A.M., Rodriguez V.P., Sipes G.I. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats. Toxicol. Sci. 2007, 96:237-245.
26. Lai D.Y., Kacew S., Dekant W. Tetrabromobisphenol A (TBBPA): possible modes of action of toxicity and carcinogenicity in rodents. Food Chem. Toxicol. 2015, 80:206-214.
27. Matsumoto J., Iwano H., Inoue H., Iwano N., Yamashiki N., Yokota H. Metabolic barrier against bisphenol A in a rat uterine endometrium. Toxicol. Sci. 2007, 99(1):118-125.
28. National Toxicology Program (NTP) Technical Report on the Toxicology Studies of Tetrabromobisphenol A (CAS no. 79-94-7) in F344/NTac Rats and B6C3F1/N Mice and Toxicology and Carcinogenesis Studies of Tetrabromobisphenol A in Wistar Han [Crl:WI(Han)] Rats and B6C3F1/N Mice (Gavage Studies) 2014, National Institutes of Health, Research Triangle Park, NC.
29. Osmitz, et al. Subchronic toxicology of tetrabromobisphenol-A (TBBPA) in rats. Hum. Exp. Toxicol. 2016, (accepted for publication).
30. Rizner T.L. Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer. Mol. Cell. Endocrinol. 2013, 381(1-2):124-139. 10.1016/j.mce.2013.07.026.
31. Schauer U.M., Volkel W., Dekant W. Toxicokinetics of tetrabromobisphenol A in humans and rats after oral administration. Toxicol. Sci. 2006, 91:49-58.
32. Shi Z.X., Wu Y.N., Li J.G., Zhao Y.F., Feng J.F. Dietary exposure assessment of Chinese adults and nursing infants to tetrabromobisphenol-A and hexabromocyclododecanes: occurrence measurements in foods and human milk. Environ. Sci. Technol. 2009, 43(12):4314-4319.
33. Shi Z., Jiao Y., Hu Y., Sun Z., Zhou X., Feng J., Li J., Wu Y. Levels of tetrabromobisphenol A, hexabromocyclododecanes and polybrominated diphenyl ethers in human milk from the general population in Beijing, China. Sci. Total Environ. 2013, 452-453:10-18.
34. Sjodin A., Patterson D.G., Bergman A. A review on human exposure to brominated flame retardants-particularly polybrominated diphenyl ethers. Environ. Int. 2003, 29(6):829-839.
35. Slikker W., Anderson M.E., Bogdanffy M.S., Bus J.S., Cohen S.D., Conolly R.B., David R.M., Doerrer H.G., Dorman D.C., Gaylor D.W., Hattis D., Rogers J.M., Setzer R.W., Swenbery J.A., Wallace K. Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol. Appl. Pharmacol. 2004, 201(3):226-294.
36. U.S.Environmental Protection Agency (USEPA) TSCA Work Plan Chemical Problem Formulation and Initial Assessment: Tetrabromobisphenol A and Related Chemicals Cluster Flame Retardants 2015, U.S. Environmental Protection Agency, EPA Document #740-R1-4004.
37. Utsunomiya H., Ito K., Suzuki T., Kitamura T., Kaneko C., Nakata T., Niikura H., Okamura K., Yaegashi N., Sasano H. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clin. Cancer Res. 2004, 10:5850-5856.
38. Van der Ven L.T., Van de Kuil T., Verhoef A., Verwer C.M., Lilienthal H., Leonards P.E., Schauer U.M., Canton R.F., Litens S., De Jong F.H., Visser T.J., Dekant W., Stern N., Hakansson H., Slob W., Van den Berg M., Vos J.G., Piersma A.H. Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study. Toxicology 2008, 245(1-2):76-89.
39. Wang L.Q., James M.O. Inhibition of sulfotransferases by xenobiotics. Curr. Drug Metab. 2006, 7:83-104.
40. Webb L.J., Miles K.K., Auyeung D.J., Kessler F.K., Ritter J.K. Analysis of substrate specificities and tissue expression of rat UDP-glucuronosyltransferases UGT1A7 and UGT1A8. Drug Metab. Dispos. 2005, 33:77-82.
41. Wikoff D., Thompson C., Perry C., White M., Borghoff S., Fitzgerald L., Haws L.C. Development of toxicity values and exposure estimates for tetrabromobisphenol A: application in a margin of exposure assessment?. J. Appl. Toxicol. 2015, 35(11):1292-1308.
42. Wikoff D., Rager J., Haws L.A., Borghoff S.J. A high dose mode of action for tetrabromobisphenol A-induced uterine adenocarcinomas in Wistar Han rats: a critical evaluation of key events in an adverse outcome pathway framework. Regul. Toxicol. Pharmacol. 2016, (accepted for publication).
43. Xu Y., Liu X., Gui F., Ning Y., Zhi X., Wang X., Chen S., Yin L., Li X. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers. Cancer Sci. 2012, 103:1000-1009.